FORM 10-Q



                       SECURITIES AND EXCHANGE COMMISSION

                             Washington, D.C. 20549


          QUARTERLY REPORT UNDER SECTION 13 OR 15 (d) OF THE SECURITIES
                              EXCHANGE ACT OF 1934


         (Mark One)
         { X }  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE
                SECURITIES EXCHANGE ACT OF 1934

         For the quarterly period ended                March 31, 2003

         {   }  TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
                SECURITIES EXCHANGE ACT OF 1934

         For the transition period from                     to


         For Quarter Ended March 31, 2003   Commission file number   000-17596

         Meridian Healthcare Growth and Income Fund Limited Partnership
             (Exact Name of Registrant as Specified in its Charter)


                  Delaware                                 52-1549486
          (State or Other Jurisdiction of               (I.R.S. Employer
          Incorporation or Organization)              Identification Number)



         225 East Redwood Street, Baltimore, Maryland         21202
           (Address of Principal Executive Offices)        (Zip Code)

       Registrant's Telephone Number, Including Area Code: (410) 727-4083

                                       N/A
              (Former Name, Former Address, and Former Fiscal Year,
                         if Changed Since Last Report.)


           Indicate by check mark whether the registrant (1) has filed all
         reports required to be filed by Section 13 or 15 (d) of the Securities
         Exchange Act of 1934 during the preceding 12 months (or for such
         shorter period that the registrant was required to file such reports),
         and (2) has been subject to such filing requirements for the past 90
         days.

                       Yes     X                   No

           Indicate by check mark whether the registrant is an accelerated filer
         (as defined in Rule 12b-2 of the Act).

                  Yes                            No     X



<PAGE>

         MERIDIAN HEALTHCARE GROWTH AND INCOME FUND LIMITED PARTNERSHIP


                                      INDEX


                                                                       Page No.

CAUTIONARY STATEMENT REGARDING FORWARD LOOKING STATEMENTS                 2

Part I.  Financial Information


     Item 1.  Financial Statements

              Condensed Consolidated Balance Sheets                       3
              Condensed Consolidated Statements of Earnings               4
              Condensed Consolidated Statements of Partners' Capital      5
              Condensed Consolidated Statements of Cash Flows             6
              Notes to Condensed Consolidated Financial Statements      7-9


     Item 2.  Management's Discussion and Analysis of
                 Financial Condition and Results of Operations        10-12


     Item 3.  Quantitative and Qualitative Disclosures
                 About Market Risk                                       13


    Item 4.   Controls and Procedures13

Part II.   Other Information


     Item 1. through Item 6.                                          13-22

     Signatures                                                          23






<PAGE>


         MERIDIAN HEALTHCARE GROWTH AND INCOME FUND LIMITED PARTNERSHIP




            Cautionary Statement Regarding Forward Looking Statements

Statements made in this report, and in our other public filings, which are not
historical facts contain "forward-looking" statements (as defined in the Private
Securities Litigation Reform Act of 1995) that involve risks and uncertainties
and are subject to change at any time. These forward-looking statements may
include, but are not limited to:
o     certain statements in "Management's Discussion and Analysis of
      Financial Condition and Results of Operations," such as our ability to
      meet our liquidity needs, scheduled debt and interest payments and
      expected future capital expenditure requirements; and

o    certain statements in the Notes to Condensed Consolidated Financial
     Statements (Unaudited).

 The forward-looking statements involve known and unknown risks, uncertainties
 and other factors that are, in some cases, beyond our control. You are
 cautioned that these statements are not guarantees of future performance and
 that actual results and trends in the future may differ materially.

 Factors that could cause actual results to differ materially include, but are
not limited to the following:

o     changes in the reimbursement rates or methods of payment from Medicare
      and Medicaid, or the implementation of other measures to reduce the
      reimbursement for our services;

o    the expiration of enactments providing for additional governmental funding;

o    efforts of third party payors to control costs;

o    the impact of federal and state regulations;

o    changes in payor mix and payment methodologies;

o    further consolidation of managed care organizations and other third party
     payors;

o    competition in our business;

o    an increase in insurance costs and potential liability for losses not
     covered by, or in excess of, our insurance;

o    competition for qualified staff in the healthcare industry;

o    our ability to control operating costs, and generate sufficient cash flow
     to meet operational and financial requirements; and

o    an economic downturn or changes in the laws affecting our business in those
     markets in which we operate.

 These risks are described in more detail in our Annual Report on Form 10-K.

In addition to these factors and any risks and uncertainties specifically
identified in the text surrounding forward-looking statements, any statements in
this report or the reports and other documents filed by us with the SEC that
warn of risks or uncertainties associated with future results, events or
circumstances also identify factors that could cause actual results to differ
materially from those expressed in or implied by the forward-looking statements.

All subsequent written and oral forward-looking statements attributable to us or
any person acting on our behalf are expressly qualified in their entirety by the
cautionary statements contained or referred to in this section. We do not
undertake any obligation to release publicly any revisions to these
forward-looking statements to reflect events or circumstances after the date of
this report or to reflect the occurrence of unanticipated events, except as may
be required under applicable securities law.






                                      -2-

<PAGE>

         MERIDIAN HEALTHCARE GROWTH AND INCOME FUND LIMITED PARTNERSHIP
                      Condensed Consolidated Balance Sheets
                             (Dollars in thousands)
<TABLE>
<CAPTION>
                                                                              March 31,
                                                                                2003          December 31,
                                                                             (Unaudited)           2002
                                                                          ----------------   ---------------
Assets
Current Assets
<S>                                                                       <C>                <C>
   Cash and cash equivalents                                              $           922    $          740
   Accounts receivable, net                                                         7,922             7,809
   Estimated third-party payor settlements                                            658               840
   Prepaid expenses and other current assets                                          966               766
                                                                          ----------------   ---------------
       Total current assets                                                        10,468            10,155
                                                                          ----------------   ---------------

Property and equipment, net of accumulated depreciation                            31,144            31,231
                                                                          ----------------   ---------------

Other assets
   Goodwill, net                                                                    4,237             4,237
   Loan acquisition costs, net                                                        415               216
                                                                          ----------------   ---------------
                                                                                    4,652             4,453
                                                                          ----------------   ---------------


       Total assets                                                       $        46,264    $       45,839
                                                                          ================   ===============

Liabilities and Partners' Capital
Current liabilities
   Current portion of long-term debt                                      $           678    $          606
   Line of credit                                                                     227                 -
   Accrued compensation and related costs                                              43                 3
   Accounts payable and other accrued expenses                                      3,420             2,808
   Estimated third party payor settlements                                          2,323             2,527
                                                                          ----------------   ---------------
       Total current liabilities                                                    6,691             5,944
                                                                          ----------------   ---------------

Deferred management fee payable                                                     1,032             1,021
Loan payable to the Development General Partner                                     1,304             1,292
Long-term debt                                                                     22,043            22,271
                                                                          ----------------   ---------------
                                                                                   24,379            24,584
                                                                          ----------------   ---------------

Partners' capital
   General partners                                                                  (163)             (162)
   Assignee limited partners; 1,540,040
     units issued and outstanding                                                  15,357            15,473
                                                                          ----------------   ---------------
       Total partners' capital                                                     15,194            15,311
                                                                          ----------------   ---------------

       Total liabilities and
         partners' capital                                                $        46,264    $       45,839
                                                                          ================   ===============
</TABLE>




     See accompanying notes to condensed consolidated financial statements.

                                       -3-

<PAGE>

         MERIDIAN HEALTHCARE GROWTH AND INCOME FUND LIMITED PARTNERSHIP
                  Condensed Consolidated Statements of Earnings
                                   (Unaudited)
                 (Dollars in thousands except per unit amounts)

<TABLE>
<CAPTION>

                                                                      Three Months Ended
                                                              ----------------------------------
                                                                  March 31,         March 31,
                                                                    2003              2002
                                                              ----------------   ---------------
Revenues
<S>                                                           <C>                <C>
   Medicaid and Medicare patients                             $        13,086    $       12,534
   Private patients                                                     2,303             2,511
   Investment and other income                                             18                25
                                                              ----------------   ---------------
                                                                       15,407            15,070
                                                              ----------------   ---------------

Expenses
   Operating, including $2,503, and
       $2,504 to related parties                                       13,189            12,053
   Management and administration fees
       to related parties                                                 833               829
   General and administrative                                             102               261
   Depreciation and amortization                                          504               501
   Interest expense                                                       458               592
                                                              ----------------   ---------------
                                                                       15,086            14,236
                                                              ----------------   ---------------

Net earnings                                                  $           321    $          834
                                                              ================   ===============


Net earnings per unit of assignee
   limited partnership interest
   (computed based on 1,540,040
    units)                                                    $          0.21    $         0.54
                                                              ================   ===============
</TABLE>




      See accompanying notes to condensed consolidated financial statements

                                       -4-

<PAGE>

         MERIDIAN HEALTHCARE GROWTH AND INCOME FUND LIMITED PARTNERSHIP

             Condensed Consolidated Statements of Partners' Capital
               For the Three Months Ended March 31, 2003 and 2002
                             (Unaudited) (Dollars in
                                   thousands)

<TABLE>
<CAPTION>
                                                                        Assignee
                                                      General            Limited
                                                     Partners           Partners            Total
                                                 ----------------   ----------------   ---------------

<S>                                              <C>                <C>                        <C>
Balance at December 31, 2002                     $          (162)   $        15,473            15,311

Net earnings                                                   3                318               321

Distributions to partners                                     (4)              (434)             (438)
                                                 ----------------   ----------------   ---------------

Balance at March 31, 2003                        $          (163)   $        15,357            15,194
                                                 ================   ================   ===============


Balance at December 31, 2001                     $          (153)   $        16,386            16,233

Net earnings                                                   8                826               834

Distributions to partners                                     (8)              (818)             (826)
                                                 ----------------   ----------------   ---------------

Balance at March 31, 2002                        $          (153)   $        16,394            16,241
                                                 ================   ================   ===============

</TABLE>




      See accompanying notes to condensed consolidated financial statements

                                       -5-

<PAGE>

         MERIDIAN HEALTHCARE GROWTH AND INCOME FUND LIMTIED PARTNERSHIP
                 Condensed Consolidated Statements of Cash Flows
                      For the Three Months Ended March 31,
                             (Unaudited) (Dollars in
                                   thousands)
<TABLE>
<CAPTION>
                                                                                2003              2002
                                                                          ----------------   ---------------
Cash flows from operating activities
<S>                                                                       <C>                <C>
   Net earnings                                                           $           321    $          834
   Adjustments to reconcile net earnings to net cash
     provided by operating activities
       Depreciation and amortization                                                  504               501
       Minority interest in net earnings of operating partnerships                      2                11
       Increase in loan payable to Development General Partner                         12                13
       Increase in deferred management fee payable                                     11                12
       Change in other assets and liabilities
         Accounts receivable                                                         (113)              351
         Estimated third-party payor settlements                                      (22)              (98)
         Prepaid expenses and other current assets                                   (200)             (147)
         Accrued compensation and related costs                                        40              (238)
         Accounts payable and other accrued expenses                                  610              (716)
                                                                          ----------------   ---------------

Net cash provided by operating activities                                           1,165               523
                                                                          ----------------   ---------------

Cash flows from investing activities -
   additions to property and equipment                                               (389)             (386)
                                                                          ----------------   ---------------


Cash flows from financing activities
   Repayment of long-term debt                                                       (156)             (121)
   Loan acquisition costs                                                            (227)                -
   Line of credit                                                                     227                 -
   Distributions to partners                                                         (438)             (826)
                                                                          ----------------   ---------------

Net cash used in financing activities                                                (594)             (947)
                                                                          ----------------   ---------------

Net (decrease) increase in cash and cash equivalents                                  182              (810)
Cash and cash equivalents
   Beginning of period                                                                740             2,066
                                                                          ----------------   ---------------

   End of period                                                          $           922    $        1,256
                                                                          ================   ===============
</TABLE>



     See accompanying notes to condensed consolidated financial statements.

                                       -6-
<PAGE>


         MERIDIAN HEALTHCARE GROWTH AND INCOME FUND LIMITED PARTNERSHIP


              Notes to Condensed Consolidated Financial Statements
                                 March 31, 2003
                                   (Unaudited)


NOTE 1 - THE FUND AND BASIS OF PREPARATION

     Meridian  Healthcare Growth and Income Fund Limited  Partnership (the Fund)
was  organized  under the laws of the State of  Delaware  and will  continue  to
operate through December 31, 2037, unless terminated sooner under the provisions
of the Partnership Agreement. The Fund's Administrative General Partner is Brown
Healthcare,  Inc.  and  the  Fund's  Development  General  Partner  is  Meridian
Healthcare  Investments,  Inc. Brown Healthcare  Holding Co., Inc. is the Fund's
Assignor Limited Partner. Meridian Healthcare Investments,  Inc. is a subsidiary
of Genesis Health Ventures, Inc. (Genesis).

The Fund owns 98.99% limited partnership interests in each of the seven
operating partnerships. The Fund, through its seven operating partnerships,
derives substantially all of its revenue from extended healthcare provided to
nursing center residents including room and board, nursing care, drugs and other
medical services.

The accompanying condensed consolidated financial statements of Meridian
Healthcare Growth and Income Fund Limited Partnership (the "Fund") do not
include all of the information and note disclosures normally included in
financial statements prepared in accordance with accounting principles generally
accepted in the United States of America. The unaudited interim condensed
consolidated financial statements reflect all adjustments which are, in the
opinion of management, necessary to a fair statement of the results for the
interim periods presented. All such adjustments are of a normal recurring
nature.

The accompanying unaudited condensed consolidated financial statements should be
read in conjunction with the consolidated financial statements and the notes
thereto included in the Fund's Annual Report on Form 10-K for the fiscal year
ended December 31, 2002.

The Fund has made a number of estimates relating to the reporting of assets and
liabilities, revenues and expenses and the disclosure of contingent assets and
liabilities to prepare these unaudited condensed consolidated financial
statements in conformity with accounting principles generally accepted in the
United States of America. Actual results could differ from those estimates.


NOTE 2 - RELATED PARTY TRANSACTIONS

The Fund is obligated to pay Brown-Healthcare, Inc. (Administrative General
Partner) an annual administration fee of the greater of $75,000 per year or 1/2
of 1% of the Fund's annual revenues. The nursing centers owned by the operating
partnerships are managed by Meridian Healthcare, Inc., an affiliate of Meridian
Healthcare Investments, Inc. (Development General Partner), under the terms of
existing management agreements which provide for management fees equal to 5% of
the annual revenues of each nursing center. Certain of the operating
partnerships also purchase drugs and medical supplies and other services from
affiliates of the Development General Partner. Such purchases are in turn billed
to patients or third party payors at prices which on average approximate the
nursing center's cost.

Transactions with these related parties for the three months ended March 31,
2003 and 2002 are as follows:

                                                   2003              2002

    Management and administration fees        $   833,000        $   829,000
    Drug and medical supplies purchases           909,000            915,000
    Nursing and rehabilitation services         1,594,000          1,589,000
    Interest expense on borrowings                 23,000             21,000




                                      -7-
<PAGE>
         MERIDIAN HEALTHCARE GROWTH AND INCOME FUND LIMITED PARTNERSHIP


              Notes to Condensed Consolidated Financial Statements
                                 March 31, 2003
                                   (Unaudited)


NOTE 2 - RELATED PARTY TRANSACTIONS (Continued)

The Development General Partner loaned the Fund $597,000, as required by the
Cash Flow Deficit Guaranty Agreement, to support the operating deficits
generated by the Mooresville, Salisbury and Woodlands nursing centers during
each center's first two years of operations subsequent to the Fund's acquisition
of partnership interests. Loans outstanding under an arrangement, including
accumulated interest from inception of the loan at 9% per annum, were $1,304,000
at March 31, 2003 and $1,292,000 at December 31, 2002. The Fund is obligated to
repay these loans when certain specified financial criteria are met, the most
significant of which is the payment of a preferred return to the assignee
limited partners as defined in the Fund's partnership agreement.


NOTE 3 - DEBT

The Fund closed its mortgage loan refinancing with a new bank for loans totaling
$24,000,000 on June 12, 2000. The renewal terms became effective on June 12,
2000 and provide for a term of five years at an interest rate of 9.75%. Monthly
payments of $229,886 are based on a 20-year amortization schedule with a balloon
payment due at the end of the 5-year term. Effective February 1, 2003, the Fund
amended the existing mortgage. The amendment provides for a term of five years
at an interest rate of 6.5%. Monthly payments of $180,242 are based on a 20-year
amortization schedule with a mandatory prepayment option at the Bank's
discretion during the period between November 1, 2007 through May 1, 2008.

The Fund established a $4,000,000 revolving credit facility with the same
lender. As of March 31, 2003, the Fund had borrowed $227,304 under this credit
facility to fund financing fees incurred in connection with the amendment of
mortgage terms. Borrowings under the credit facility bear interest at a floating
rate, which equals the announced commercial prime rate. The bank can renew the
credit facility each year for a one-year extention.


NOTE 4 - CERTAIN SIGNIFICANT RISKS AND UNCERTAINTIES

The Fund receives revenues from Medicare, Medicaid, private insurance, self-pay
residents, and other third party payors. The healthcare industry is experiencing
the effects of the federal and state governments' trend toward cost containment,
as government and other third party payors seek to impose lower reimbursement
and utilization rates and negotiate reduced payment schedules with providers.
These cost containment measures, combined with the increasing influence of
managed care payors and competition for patients, have resulted in constrained
rates of reimbursement for services provided by the Fund.

The Medicaid and Medicare programs are highly regulated. The failure of the Fund
to comply with applicable reimbursement regulations could adversely affect its
business. The Fund monitors its receivables from third party payor programs and
reports such revenues at the net realizable value expected to be received.

On December 15, 2000, Congress passed the Benefits Improvement Protection Act
that increased the nursing component of federal prospective payment system's
rates by 16.7% (approximate) for the period from April 1, 2001 through September
30, 2002. The legislation also changed the 20% add-on to 3 of the 14
rehabilitation resource utilization group categories to a 6.7% add-on to all 14
rehabilitation resource utilization group categories beginning April 1, 2001.
The Medicare Part B consolidated billing provision of the Balance Budget
Refinement Act was repealed except for Medicare Part B therapy services and the
moratorium on the $1,500 therapy caps was extended through calendar year 2002.
These changes had a positive impact on operating results.

A number of provisions of the Balanced Budget Refinement Act and the Benefits
Improvement and Protection Act enactments, providing additional funding for
Medicare participating skilled nursing facilities, expired on September 30,
2002. The expiration of these provisions has reduced the Fund's Medicare per
diems per beneficiary, on average, by $34 (the Medicare Cliff). For Federal
fiscal year 2003, the Centers for Medicare and Medicaid Services used their
discretionary authority to continue the payment add-ons. The recently released
proposed Federal Budget for fiscal year 2004 indicates that the Centers for
Medicare and Medicaid Services will extend the add-ons described in the previous
paragraph for the coming year. It is uncertain as to whether as part of the
rule-making process the agency will propose



                                      -8-
<PAGE>
         MERIDIAN HEALTHCARE GROWTH AND INCOME FUND LIMITED PARTNERSHIP


              Notes to Condensed Consolidated Financial Statements
                                 March 31, 2003
                                   (Unaudited)


NOTE 4 - CERTAIN SIGNIFICANT RISKS AND UNCERTAINTIES  (Continued)

changes in how the add-ons are applied. Proposed rules are normally released in
late April with a 60-day public comment period. By law, final rules for coming
fiscal year must be issued by August 1. Effective October 1, 2002, Medicare
rates adjusted for the Medicare Cliff were increased by a 2.6% annual market
basket adjustment. For the Fund, the net impact of these provisions is estimated
to adversely impact annual revenue and operating income by approximately $1.2
million.

The recent economic downturn is having a detrimental effect on state revenues in
most jurisdictions. Budget shortfalls range from 4-5% of outlays upwards to 20%
of outlays in a handful of states. Historically these budget pressures have
translated into reductions in state spending. Given that Medicaid outlays are a
significant component of state budgets, the Fund expects continuing cost
containment pressures on Medicaid outlays for nursing homes in the states in
which it operates. State-specific details are just emerging as state
legislatures begin the tasks of approving state budgets.

The plight of state governments has helped to elevate issues related to Medicaid
onto the national agenda. During the 107th Congress, the U.S. Senate passed
legislation providing states with a temporary increase in the Federal Matching
Assistance Percentage. This legislation was not passed, however, it has been
reintroduced in both the U.S. Senate and the U.S. House of Representatives. In
his proposed federal budget for fiscal year 2004, the President offered modest
additional fiscal support and advanced several ideas for revising the program.
The 108th Congress is expected to consider an array of Medicaid reform
proposals.

It is not possible to fully quantify the effect of potential legislative or
regulatory changes, the administration of such legislation or any other
governmental initiatives on the Fund's business. Accordingly, there can be no
assurance that the impact of these changes or any future healthcare legislation
will not further adversely affect the Fund's business. There can be no assurance
that payments under governmental and private third party payor programs will be
timely, will remain at levels comparable to present levels or will, in the
future, be sufficient to cover the costs allocable to patients eligible for
reimbursement pursuant to such programs. The Fund's financial condition and
results of operations may be affected by the reimbursement process, which in the
healthcare industry is complex and can involve lengthy delays between the time
that revenue is recognized and the time that reimbursement amounts are settled.


                                      -9-

<PAGE>


         MERIDIAN HEALTHCARE GROWTH AND INCOME FUND LIMITED PARTNERSHIP


                Management's Discussion and Analysis of Financial
                       Condition and Results of Operations



Liquidity and Capital Resources

     The Fund closed its mortgage loan refinancing with a new bank for loans
totaling $24,000,000 on June 12, 2000. The renewal terms became effective on
June 12, 2000 and provide for a term of five years at an interest rate of 9.75%.
Monthly payments were based on a 20-year amortization schedule with a balloon
payment due at the end of the 5-year term. Effective February 1, 2003, the Fund
amended the existing mortgage. The amendment provides for a term of five years
at an interest rate of 6.5%. Monthly payments of $180,242 are based on a 20-year
amortization schedule with a mandatory prepayment option at the Bank's
discretion during the period between November 1, 2007 through May 1, 2008.

     The Fund also has a $4,000,000 line of credit with the same lender under
terms similar to the mortgage loan terms described above, except that the line
of credit facility requires annual reaffirmation. As of March 31, 2003, the Fund
had borrowed $227,304 under this credit facility to fund financing fees incurred
in connection with the amendment of mortgage terms, discussed above. The Fund
will perform approximately $1 million of non-routine capital improvements to
enhance the functionality and marketability of its Maryland centers. The Fund
expects to draw on its line of credit facility to fund these improvements, as
necessary.

     The Fund's working capital (excluding the current portion of long-term
debt) decreased $362,000 to $4,455,000 at March 31, 2003 as compared to
$4,817,000 at December 31, 2002. The Fund has sufficient liquid assets and other
available credit resources to satisfy its operating expenditures and anticipated
routine capital improvements at each of the seven nursing home facilities.

     Cash flow from operating activities was $1,165,000 for the three-month
period ended March 31, 2003 as compared to $523,000 for the same period of 2002.
This increase in cash flow was due primarily to an increase in accounts payable
and accrued expenses resulting from timing of payments, offset by lower earnings
due to increased operating expenses at the facilities.

     Cash used in investing activities for the three-month period ended March
31, 2003 was $389,000 and included improvements to the Fund's seven operating
facilities. Similar improvements made during the first three months of 2002 were
$386,000.

     Cash used in financing activities for the three-month period ended March
31, 2003 included the repayment of long term debt of $156,000 and distributions
to partners totaling $438,000.

     The Fund believes that the short-term liquidity needs will be met through
expected cash flow from operations and available working capital from the
existing revolving credit facility.

     Between 1988 and 1989 the Development General Partner loaned the Fund
$597,000 to support operating deficits generated by the Mooresville, Salisbury
and Woodlands nursing centers during each centers' first two years of operation.
Loans outstanding under this arrangement, including interest at 9% per annum,
were $1,304,000 at March 31, 2003 and $1,292,000 at December 31, 2002.

     On May 15, 2003 the Fund will make its first quarter 2003 distribution to
partners of $583,000, representing a 6% return. Based on operating results
through the first quarter and the 2003 budget, the Fund expects a similar
distribution throughout the remainder of the year as operations have been
affected by reduced Medicare revenues resulting from the expiration of Benefits
Improvement and Protection Act and Balanced Budget Refinement Act legislation on
September 30, 2002.

     The major challenge to the Fund in the foreseeable future is to control
operating expenses, to maintain a quality mix of patients and to increase the
overall census at each of the facilities.



                                      -10-

<PAGE>


         MERIDIAN HEALTHCARE GROWTH AND INCOME FUND LIMITED PARTNERSHIP

               Management's Discussion and Analysis of Financial
                       Condition and Results of Operations


Revenue Sources

     The Fund receives revenues from Medicare, Medicaid, private insurance,
self-pay residents, and other third party payors. The healthcare industry is
experiencing the effects of the federal and state governments' trend toward cost
containment, as government and other third party payors seek to impose lower
reimbursement and utilization rates and negotiate reduced payment schedules with
providers. These cost containment measures, combined with the increasing
influence of managed care payors and competition for patients, have resulted in
constrained rates of reimbursement for services provided by the Fund.

     A number of provisions of the Balanced Budget Refinement Act and the
Benefits Improvement and Protection Act enactments, providing additional funding
for Medicare participating skilled nursing facilities, expired on September 30,
2002. The expiration of these provisions has reduced the Fund's Medicare per
diems per beneficiary, on average, by $34 (the Medicare Cliff). For Federal
fiscal year 2003, the Centers for Medicare and Medicaid Services used their
discretionary authority to continue the payment add-ons. The recently released
proposed Federal Budget for fiscal year 2004 indicates that the Centers for
Medicare and Medicaid Services will extend the add-ons described in the previous
paragraph for the coming year. It is uncertain as to whether as part of the
rule-making process the agency will propose changes in how the add-ons are
applied. Proposed rules are normally released in late April with a 60-day public
comment period. By law, final rules for coming fiscal year must be issued by
August 1. Effective October 1, 2002, Medicare rates adjusted for the Medicare
Cliff were increased by a 2.6% annual market basket adjustment. For the Fund,
the net impact of these provisions is estimated to adversely impact annual
revenue and operating income by approximately $1.2 million.

     The recent economic downturn is having a detrimental effect on state
revenues in most jurisdictions. Budget shortfalls range from 4-5% of outlays
upwards to 20% of outlays in a handful of states. Historically these budget
pressures have translated into reductions in state spending. Given that Medicaid
outlays are a significant component of state budgets, the Fund expects
continuing cost containment pressures on Medicaid outlays for nursing homes in
the states in which it operates. State-specific details are just emerging as
state legislatures begin the tasks of approving state budgets.

     The plight of state governments has helped to elevate issues related to
Medicaid onto the national agenda. During the 107th Congress, the U.S. Senate
passed legislation providing states with a temporary increase in the Federal
Matching Assistance Percentage. This legislation was not passed, however, it has
been reintroduced in both the U.S. Senate and the U.S. House of Representatives.
In his proposed federal budget for fiscal year 2004, the President offered
modest additional fiscal support and advanced several ideas for revising the
program. The 108th Congress is expected to consider an array of Medicaid reform
proposals.

     It is not possible to fully quantify the effect of potential legislative or
regulatory changes, the administration of such legislation or any other
governmental initiatives on the Fund's business. Accordingly, there can be no
assurance that the impact of these changes or any future healthcare legislation
will not further adversely affect the Fund's business. There can be no assurance
that payments under governmental and private third party payor programs will be
timely, will remain at levels comparable to present levels or will, in the
future, be sufficient to cover the costs allocable to patients eligible for
reimbursement pursuant to such programs. The Fund's financial condition and
results of operations may be affected by the reimbursement process, which in the
healthcare industry is complex and can involve lengthy delays between the time
that revenue is recognized and the time that reimbursement amounts are settled.

Results of Operations

     Net earnings for the Fund were $321,000 for the three months ended March
31, 2003 as compared to $834,000 for the same period in fiscal year 2002. The
decrease in earnings is primarily due to an increase in operating costs
partially offset by lower administrative costs and an increase in Medicaid and
Medicare patients revenue.



                                      -11-

<PAGE>


         MERIDIAN HEALTHCARE GROWTH AND INCOME FUND LIMITED PARTNERSHIP

               Management's Discussion and Analysis of Financial
                       Condition and Results of Operations


Results of Operations (continued)

     Overall revenues of $15,407,000 increased $337,000 or 2.2% for the three
months ended March 31, 2003 compared to the same period in fiscal year 2002. The
increase in revenue is primarily due to an increase in Medicaid revenue.
Medicaid and Medicare patient revenues increased $552,000 to $13,086,000 for the
first quarter of 2003 compared to the first quarter of fiscal year 2002.
Medicaid revenue for the three months ended March 31, 2003 increased $518,000
compared to the same period in the prior year. This increase is primarily due to
an overall Medicaid rate increase of approximately 6.5%. Medicare revenue of
$3,992,000 increased $34,000 or .9% for the three month period ended March 31,
2003 compared to the same period in fiscal year 2002. The increase in Medicare
revenue is due to a growth in the Medicare census, which is partially offset by
lower rates. The average daily Medicare census increased twelve customers per
day or 9.5% to 140 for the three months ended March 31, 2003 as compared to the
same period in the prior year.

     First quarter 2003 expenses of $15,086,000 increased $850,000 or 6.0% from
$14,236,000 for the three months ended March 31, 2002.

     Operating expenses increased $1,136,000 or 9.4% in the first quarter of
2003 as compared to the same period in fiscal year 2002. This increase is
primarily due to the increased cost of nursing services, bad debt expense and
ancillary costs. Nursing costs increased $515,000 for the three months ended
March 31, 2003 as compared to the same period in fiscal year 2002. Nursing
salaries and benefits increased $543,000, which was partially offset by a
decrease in the utilization of temporary nurse staffing. Bad debt expense of
$317,000 increased $182,000 for the three month period ended March 31, 2003
compared to the same period in fiscal year 2002. Ancillary costs increased
$269,000 or 16.2% in the first quarter of 2003 as compared to the same period in
fiscal year 2002, which is attributable to the 9.5% increase in the average
daily Medicare census. The remaining increase in operating costs is due to
general inflationary cost increases.

     General and administrative expenses decreased $159,000 or 60.9% in the
first quarter of 2003 as compared to the same period in fiscal year 2002. This
decrease is primarily due to a change in New Jersey regulations which resulted
in a $190,000 reduction of a filing fee expense recognized in the fiscal year
2002. Partially offsetting the reduction in the filing fee were higher legal and
consulting expenses and general inflationary cost increases.

     Interest expense of $458,000 decreased $134,000 or 22.6% for the three
months ended March 31, 2003 as compared to the same period in the prior year.
This is due to restructuring of the term loan effective February 1, 2003
reducing the interest rate from 9.75% to 6.5%.


Critical Accounting Policies

     We consider an accounting policy to be critical if it is important to our
financial condition and results, and requires significant judgment and estimates
on the part of management in its application. Our critical accounting estimates
and the related assumptions are evaluated periodically as conditions warrant,
and changes to such estimates are recorded as new information or changed
conditions require revision. Application of the critical accounting policies
requires management's significant judgments, often as the result of the need to
make estimates of matters that are inherently uncertain. If actual results were
to differ materially from the estimates made, the reported results could be
materially affected. We believe that the following represents our critical
accounting policies, which are described in our most recent Annual Report on
Form 10-K:

o        Allowance for Doubtful Accounts
o        Revenue Recognition

       During the current quarter, we did not make any material changes to our
estimates or methods by which estimates are derived with regard to our critical
accounting policies.


                                      -12-

<PAGE>

         MERIDIAN HEALTHCARE GROWTH AND INCOME FUND LIMITED PARTNERSHIP


                          PART I. FINANCIAL INFORMATION


Item 3.     Quantitative and Qualitative Disclosures About Market Risk

     The Fund has exposure to changing interest rates and is currently not
engaged in hedging activities. Interest on the Fund's $22.9 million mortgage was
at a fixed rate of 9.75% through January 31, 2003. Effective February 1, 2003
the Fund's mortgage is at a fixed rate of 6.5%.


Item 4.   Controls and Procedures

     Within the 90-day period prior to the filing of the quarterly report, an
evaluation was carried out under the supervision and with the participation of
the Fund's management, including the Chief Executive Officer (or CEO) and Chief
Financial Officer (or CFO), of the effectiveness of our disclosure controls and
procedures. Based on that evaluation, the CEO and CFO have concluded that the
Fund's disclosure controls and procedures are effective to ensure that
information required to be disclosed by the Fund in reports that it files or
submits under the Securities Exchange Act of 1934 is recorded, processed,
summarized and reported within the time periods specified in Securities and
Exchange Commission rules and forms. Subsequent to the date of their evaluation,
there were no significant changes in the Fund's internal controls or in other
factors that could significantly affect the disclosure controls, including any
corrective actions with regard to significant deficiencies and material
weaknesses.




                           PART II. OTHER INFORMATION


Item 1.     Legal Proceedings

                  Inapplicable

Item 2.     Changes in Securities and Use of Proceeds

                  Inapplicable

Item 3.     Defaults upon Senior Securities

                  Inapplicable

Item 4.     Submission of Matters to a Vote of Security Holders

                  Inapplicable

Item 5.     Other Information

                  Inapplicable



                                      -13-

<PAGE>

         MERIDIAN HEALTHCARE GROWTH AND INCOME FUND LIMITED PARTNERSHIP



Item 6.     Exhibits and Reports on Form 8-K

a) Exhibits

     Exhibit 99.1 Certification Pursuant to 18 U.S.C. Section 1350,
     as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

     Exhibit 99.2 Certification Pursuant to 18 U.S.C. Section 1350,
     as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

     Exhibit 99.3 Certification Pursuant to 18 U.S.C. Section 1350,
     as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

     Exhibit 99.4 Certification Pursuant to 18 U.S.C. Section 1350,
     as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

     Exhibit 99.5 Certification of Principal Executive Officer Pursuant to
     Section 302 of the Sarbanes-Oxley Act of 2002.

     Exhibit 99.6 Certification of Principal Financial Officer Pursuant to
     Section 302 of the Sarbanes-Oxley Act of 2002.

     Exhibit 99.7 Certification of Principal Executive Officer Pursuant to
     Section 302 of the Sarbanes-Oxley Act of 2002.

     Exhibit 99.8 Certification of Principal Financial Officer Pursuant to
     Section 302 of the Sarbanes-Oxley Act of 2002.

b) Reports on Form 8-K: None


                                      -14-

<PAGE>
                                                             Exhibit 99.1


                   MERIDIAN HEALTHCARE GROWTH AND INCOME FUND
                               LIMITED PARTNERSHIP

                            CERTIFICATION PURSUANT TO
                               18 U.S.C. ss. 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002




In connection with the filing of Meridian Healthcare Growth and Income Fund
Limited Partnership's (the "Fund") Report on Form 10-Q for the period ending
March 31, 2003 with the Securities and Exchange Commission on the date hereof
(the "Report"), I, Robert H. Fish, the Chief Executive Officer of Meridian
Healthcare Investments, Inc., Development General Partner of the Fund, certify,
pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:

         (1)      The Report fully complies with the requirements of section
                  13(a) or 15(d) of the Securities Exchange Act of 1934; and

         (2)      The information contained in the Report fairly presents, in
                  all material respects, the financial condition and result of
                  operations of the Fund.




Date:      5/13/03                  By:   /s/   Robert H. Fish
                                     Robert H. Fish
                                     Chief Executive Officer
                                     Meridian Healthcare Investments, Inc.
                                     Development General Partner







                                      -15-


<PAGE>

                                                              Exhibit 99.2



                   MERIDIAN HEALTHCARE GROWTH AND INCOME FUND
                               LIMITED PARTNERSHIP

                            CERTIFICATION PURSUANT TO
                               18 U.S.C. ss. 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002





In connection with the filing of Meridian Healthcare Growth and Income Fund
Limited Partnership's (the "Fund") Report on Form 10-Q for the period ending
March 31, 2003 with the Securities and Exchange Commission on the date hereof
(the "Report"), I, George V. Hager, Jr., the Chief Financial Officer of Meridian
Healthcare Investments, Inc., Development General Partner of the Fund, certify,
pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:

         (1)      The Report fully complies with the requirements of section
                  13(a) or 15(d) of the Securities Exchange Act of 1934; and

         (2)      The information contained in the Report fairly presents, in
                  all material respects, the financial condition and result of
                  operations of the Fund.




Date:     5/13/03                   By:  /s/   George V. Hager, Jr.
                                      George V. Hager, Jr.
                                      Chief Financial Officer
                                      Meridian Healthcare Investments, Inc.
                                      Development General Partner




                                      -16-


<PAGE>

                                                               Exhibit 99.3


                   MERIDIAN HEALTHCARE GROWTH AND INCOME FUND
                               LIMITED PARTNERSHIP

                            CERTIFICATION PURSUANT TO
                               18 U.S.C. ss. 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002




In connection with the filing of Meridian Healthcare Growth and Income Fund
Limited Partnership's (the "Fund") Report on Form 10-Q for the period ending
March 31, 2003 with the Securities and Exchange Commission on the date hereof
(the "Report"), I, John M. Prugh, the Chief Executive Officer of Brown
Healthcare, Inc., Administrative General Partner of the Fund, certify, pursuant
to 18 U.S.C. ss. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that:

         (1)      The Report fully complies with the requirements of section
                  13(a) or 15(d) of the Securities Exchange Act of 1934; and

         (2)      The information contained in the Report fairly presents, in
                  all material respects, the financial condition and result of
                  operations of the Fund.





Date:  5/14/03                  By:   /s/    John M. Prugh
                                    John M. Prugh
                                    Chief Executive Officer
                                    Brown Healthcare, Inc.
                                    Administrative General Partner






                                      -17-


<PAGE>
                                                              Exhibit 99.4


                   MERIDIAN HEALTHCARE GROWTH AND INCOME FUND
                               LIMITED PARTNERSHIP

                            CERTIFICATION PURSUANT TO
                               18 U.S.C. ss. 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



In connection with the filing of Meridian Healthcare Growth and Income Fund
Limited Partnership's (the "Fund") Report on Form 10-Q for the period ending
March 31, 2003 with the Securities and Exchange Commission on the date hereof
(the "Report"), I, Timothy M. Gisriel, the Chief Financial Officer of Brown
Healthcare, Inc., Administrative General Partner of the Fund, certify, pursuant
to 18 U.S.C. ss. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley
Act of 2002, that:

         (1)      The Report fully complies with the requirements of section
                  13(a) or 15(d) of the Securities Exchange Act of 1934; and

         (2)      The information contained in the Report fairly presents, in
                  all material respects, the financial condition and result of
                  operations of the Fund.





Date:  5/14/03                     By:  /s/   Timothy M. Gisriel
                                        Timothy M. Gisriel
                                        Chief Financial Officer
                                        Brown Healthcare, Inc.
                                        Administrative General Partner







                                      -18-


<PAGE>
                                                              Exhibit 99.5

                   MERIDIAN HEALTHCARE GROWTH AND INCOME FUND
                               LIMITED PARTNERSHIP

                  Certification of Principal Executive Officer
            Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002


I, Robert H. Fish, certify that:

1.   I have reviewed this report of Meridian Healthcare Growth and Income Fund
     Limited Partnership;

2.   Based on my knowledge, this report does not contain any untrue statement of
     a material fact or omit to state a material fact necessary to make the
     statements made, in light of the circumstances under which such statements
     were made, not misleading with respect to the period covered by this
     report;

3.   Based on my knowledge, the financial statements, and other financial
     information included in this report, fairly present in all material
     respects the financial condition, results of operations and cash flows of
     the issuer as of, and for, the periods presented in this report;

4.   The issuer's other certifying officers and I are responsible for
     establishing and maintaining disclosure controls and procedures (as defined
     in Exchange Act Rules 13a-14 and 15d-14) for the issuer and have:

     a)  designed such disclosure controls and procedures to ensure that
         material information relating to the issuer, including its consolidated
         subsidiaries, is made known to us by others within those entities,
         particularly during the period in which this report is being prepared;

     b)  evaluated the effectiveness of the issuer's disclosure controls and
         procedures as of a date within 90 days prior to the filing date of this
         report (the "Evaluation Date"); and

     c)  presented in this report our conclusions about the effectiveness of the
         disclosure controls and procedures based on our evaluation as of the
         Evaluation Date;

5.   The issuer's other certifying officers and I have disclosed, based on our
     most recent evaluation, to the issuer's auditors and the audit committee of
     issuer's board of directors (or persons performing the equivalent
     functions):

     a)  all significant deficiencies in the design or operation of internal
         controls which could adversely affect the issuer's ability to record,
         process, summarize and report financial data and have identified for
         the issuer's auditors any material weaknesses in internal controls; and

     b)  any fraud, whether or not material, that involves management or other
         employees who have a significant role in the issuer's internal
         controls; and

6.   The issuer's other certifying officers and I have indicated in this report
     whether there were significant changes in internal controls or in other
     factors that could significantly affect internal controls subsequent to the
     date of our most recent evaluation, including any corrective actions with
     regard to significant deficiencies and material weaknesses.



     Date:     5/13/03                    By:  /s/     Robert H. Fish
                                            Robert H. Fish
                                            Chief Executive Officer
                                            Meridian Healthcare Investments,Inc.
                                            Development General Partner



                                      -19-


<PAGE>
                                                              Exhibit 99.6

                   MERIDIAN HEALTHCARE GROWTH AND INCOME FUND
                               LIMITED PARTNERSHIP

                  Certification of Principal Financial Officer
            Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002


I, George V. Hager, Jr., certify that:

1.   I have reviewed this report of Meridian Healthcare Growth and Income Fund
     Limited Partnership;

2.   Based on my knowledge, this report does not contain any untrue statement of
     a material fact or omit to state a material fact necessary to make the
     statements made, in light of the circumstances under which such statements
     were made, not misleading with respect to the period covered by this
     report;

3.   Based on my knowledge, the financial statements, and other financial
     information included in this report, fairly present in all material
     respects the financial condition, results of operations and cash flows of
     the issuer as of, and for, the periods presented in this report;

4.   The issuer's other certifying officers and I are responsible for
     establishing and maintaining disclosure controls and procedures (as defined
     in Exchange Act Rules 13a-14 and 15d-14) for the issuer and have:

     a)  designed such disclosure controls and procedures to ensure that
         material information relating to the issuer, including its consolidated
         subsidiaries, is made known to us by others within those entities,
         particularly during the period in which this report is being prepared;

     b)  evaluated the effectiveness of the issuer's disclosure controls and
         procedures as of a date within 90 days prior to the filing date of this
         report (the "Evaluation Date"); and

     c)  presented in this report our conclusions about the effectiveness of the
         disclosure controls and procedures based on our evaluation as of the
         Evaluation Date;

5.   The issuer's other certifying officers and I have disclosed, based on our
     most recent evaluation, to the issuer's auditors and the audit committee of
     issuer's board of directors (or persons performing the equivalent
     functions):

     a)  all significant deficiencies in the design or operation of internal
         controls which could adversely affect the issuer's ability to record,
         process, summarize and report financial data and have identified for
         the issuer's auditors any material weaknesses in internal controls; and

     b)  any fraud, whether or not material, that involves management or other
         employees who have a significant role in the issuer's internal
         controls; and

6.   The issuer's other certifying officers and I have indicated in this report
     whether there were significant changes in internal controls or in other
     factors that could significantly affect internal controls subsequent to the
     date of our most recent evaluation, including any corrective actions with
     regard to significant deficiencies and material weaknesses.



     Date:  5/13/03                      By:     /s/  George V. Hager, Jr.
                                           George V. Hager, Jr.
                                           Chief Financial Officer
                                           Meridian Healthcare Investments, Inc.
                                           Development General Partner



                                      -20-


<PAGE>

                                                                Exhibit 99.7

                   MERIDIAN HEALTHCARE GROWTH AND INCOME FUND
                               LIMITED PARTNERSHIP

                  Certification of Principal Executive Officer
            Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002


I, John M. Prugh, certify that:

1.   I have reviewed this report of Meridian Healthcare Growth and Income Fund
     Limited Partnership;

2.   Based on my knowledge, this report does not contain any untrue statement of
     a material fact or omit to state a material fact necessary to make the
     statements made, in light of the circumstances under which such statements
     were made, not misleading with respect to the period covered by this
     report;

3.   Based on my knowledge, the financial statements, and other financial
     information included in this report, fairly present in all material
     respects the financial condition, results of operations and cash flows of
     the issuer as of, and for, the periods presented in this report;

4.   The issuer's other certifying officers and I are responsible for
     establishing and maintaining disclosure controls and procedures (as defined
     in Exchange Act Rules 13a-14 and 15d-14) for the issuer and have:

     a)  designed such disclosure controls and procedures to ensure that
         material information relating to the issuer, including its consolidated
         subsidiaries, is made known to us by others within those entities,
         particularly during the period in which this report is being prepared;

     b)  evaluated the effectiveness of the issuer's disclosure controls and
         procedures as of a date within 90 days prior to the filing date of this
         report (the "Evaluation Date"); and

     c)  presented in this report our conclusions about the effectiveness of the
         disclosure controls and procedures based on our evaluation as of the
         Evaluation Date;

5.   The issuer's other certifying officers and I have disclosed, based on our
     most recent evaluation, to the issuer's auditors and the audit committee of
     issuer's board of directors (or persons performing the equivalent
     functions):

     a)  all significant deficiencies in the design or operation of internal
         controls which could adversely affect the issuer's ability to record,
         process, summarize and report financial data and have identified for
         the issuer's auditors any material weaknesses in internal controls; and

     b)  any fraud, whether or not material, that involves management or other
         employees who have a significant role in the issuer's internal
         controls; and

6.   The issuer's other certifying officers and I have indicated in this report
     whether there were significant changes in internal controls or in other
     factors that could significantly affect internal controls subsequent to the
     date of our most recent evaluation, including any corrective actions with
     regard to significant deficiencies and material weaknesses.



     Date:  5/14/03                         By:   /s/    John M. Prugh
                                                 John M. Prugh
                                                 Chief Executive Officer
                                                 Brown Healthcare, Inc.
                                                 Administrative General Partner



                                      -21-


<PAGE>

                                                              Exhibit 99.8

                   MERIDIAN HEALTHCARE GROWTH AND INCOME FUND
                               LIMITED PARTNERSHIP

                  Certification of Principal Financial Officer
            Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002


I, Timothy M. Gisriel, certify that:

1.   I have reviewed this report of Meridian Healthcare Growth and Income Fund
     Limited Partnership;

2.   Based on my knowledge, this report does not contain any untrue statement of
     a material fact or omit to state a material fact necessary to make the
     statements made, in light of the circumstances under which such statements
     were made, not misleading with respect to the period covered by this
     report;

3.   Based on my knowledge, the financial statements, and other financial
     information included in this report, fairly present in all material
     respects the financial condition, results of operations and cash flows of
     the issuer as of, and for, the periods presented in this report;

4.   The issuer's other certifying officers and I are responsible for
     establishing and maintaining disclosure controls and procedures (as defined
     in Exchange Act Rules 13a-14 and 15d-14) for the issuer and have:

     a)  designed such disclosure controls and procedures to ensure that
         material information relating to the issuer, including its consolidated
         subsidiaries, is made known to us by others within those entities,
         particularly during the period in which this report is being prepared;

     b)  evaluated the effectiveness of the issuer's disclosure controls and
         procedures as of a date within 90 days prior to the filing date of this
         report (the "Evaluation Date"); and

     c)  presented in this report our conclusions about the effectiveness of the
         disclosure controls and procedures based on our evaluation as of the
         Evaluation Date;

5.   The issuer's other certifying officers and I have disclosed, based on our
     most recent evaluation, to the issuer's auditors and the audit committee of
     issuer's board of directors (or persons performing the equivalent
     functions):

     a)  all significant deficiencies in the design or operation of internal
         controls which could adversely affect the issuer's ability to record,
         process, summarize and report financial data and have identified for
         the issuer's auditors any material weaknesses in internal controls; and

     b)  any fraud, whether or not material, that involves management or other
         employees who have a significant role in the issuer's internal
         controls; and

6.   The issuer's other certifying officers and I have indicated in this report
     whether there were significant changes in internal controls or in other
     factors that could significantly affect internal controls subsequent to the
     date of our most recent evaluation, including any corrective actions with
     regard to significant deficiencies and material weaknesses.



     Date:    5/14/03                       By:   /s/   Timothy M. Gisriel
                                                 Timothy M. Gisriel
                                                 Chief Financial Officer
                                                 Brown Healthcare, Inc.
                                                 Administrative General Partner



                                      -22-

<PAGE>

         MERIDIAN HEALTHCARE GROWTH AND INCOME FUND LIMITED PARTNERSHIP


                                   SIGNATURES




Pursuant to the requirements of Section 13 or 15 (d) of the Securities Exchange
Act of 1934, as amended, the registrant has duly caused this report to be signed
on its behalf by the undersigned, thereunto duly authorized.


                                  MERIDIAN HEALTHCARE GROWTH AND INCOME FUND
                                                  LIMITED PARTNERSHIP




DATE:   05/14/03                   By:   /s/  John M. Prugh
                                      John M. Prugh
                                      President and Director
                                      Brown-Healthcare, Inc.
                                      Administrative General Partner




DATE:   05/14/03                   By:  /s/  Timothy M. Gisriel
                                       Timothy M. Gisriel
                                       Treasurer
                                       Brown Healthcare, Inc.
                                       Administrative General Partner







                                      -23-